OCT Stock Overview Develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. More details
Rewards Risk Analysis No risks detected for OCT from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Add noteInnospec Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Innospec Historical stock prices Current Share Price US$104.00 52 Week High US$122.00 52 Week Low US$94.00 Beta 1.07 1 Month Change -8.77% 3 Month Change 4.00% 1 Year Change -7.14% 3 Year Change 33.33% 5 Year Change 13.04% Change since IPO 478.10%
Recent News & Updates
Dividend of US$0.79 announced Nov 11
Third quarter 2024 earnings released: EPS: US$1.34 (vs US$1.58 in 3Q 2023) Nov 06
Innospec Inc. to Report Q3, 2024 Results on Nov 06, 2024 Oct 04
Executive VP & CFO recently sold €1.0m worth of stock Aug 29
Second quarter 2024 earnings released: EPS: US$1.25 (vs US$1.16 in 2Q 2023) Aug 07
Now 22% overvalued after recent price rise Jul 17 See more updates
Dividend of US$0.79 announced Nov 11
Third quarter 2024 earnings released: EPS: US$1.34 (vs US$1.58 in 3Q 2023) Nov 06
Innospec Inc. to Report Q3, 2024 Results on Nov 06, 2024 Oct 04
Executive VP & CFO recently sold €1.0m worth of stock Aug 29
Second quarter 2024 earnings released: EPS: US$1.25 (vs US$1.16 in 2Q 2023) Aug 07
Now 22% overvalued after recent price rise Jul 17
Innospec Inc. to Report Q2, 2024 Results on Aug 06, 2024 Jul 04
Innospec Inc. to Report Q2, 2024 Results on Aug 07, 2024 Jul 02
Now 21% overvalued after recent price rise Jun 04
Now 23% overvalued after recent price rise May 12
Innospec Inc. Declares Semi-Annual Dividend, Payable on May 31, 2024 May 11
First quarter 2024 earnings released: EPS: US$1.66 (vs US$1.34 in 1Q 2023) May 10
Now 20% undervalued Apr 10
Innospec Inc. to Report Q1, 2024 Results on May 09, 2024 Apr 06
Innospec Inc. Announces Retirement of Philip Boon, Executive Vice President and Chief Operating Officer Effective March 31, 2025 Apr 03
Innospec Inc., Annual General Meeting, May 10, 2024 Mar 29
Senior VP recently sold €290k worth of stock Mar 08
President recently sold €1.1m worth of stock Feb 28
Full year 2023 earnings released: EPS: US$5.60 (vs US$5.37 in FY 2022) Feb 14 Innospec Inc. (NasdaqGS:IOSP) acquired QGP Química Geral S.A. Dec 12
Insufficient new directors Dec 01
Third quarter 2023 earnings released: EPS: US$1.58 (vs US$1.56 in 3Q 2022) Nov 09
Innospec Inc. Declares Semi-Annual Dividend for the Second Half of 2023, Payable on November 27, 2023 Nov 08
Innospec Inc. to Report Q3, 2023 Results on Nov 07, 2023 Aug 13
Second quarter 2023 earnings released: EPS: US$1.16 (vs US$1.30 in 2Q 2022) Aug 09
Innospec Inc. to Report Q2, 2023 Results on Aug 08, 2023 Jul 07
Upcoming dividend of US$0.69 per share at 1.4% yield May 12
Innospec Inc. Declares Semi-Annual Dividend, Payable on May 31, 2023 May 05
First quarter 2023 earnings released: EPS: US$1.34 (vs US$1.47 in 1Q 2022) May 04
President recently sold €1.9m worth of stock Mar 03
Full year 2022 earnings released: EPS: US$5.37 (vs US$3.78 in FY 2021) Feb 23
Innospec Inc. to Report Q4, 2022 Results on Feb 21, 2023 Jan 11
Senior VP recently bought €77k worth of stock Dec 07
Third quarter 2022 earnings released: EPS: US$1.56 (vs US$0.95 in 3Q 2021) Nov 10
Innospec Inc. Declares Semi-Annual Dividend, Payable on November 28, 2022 Nov 09
Innospec Inc. to Report Q3, 2022 Results on Nov 08, 2022 Oct 07
Second quarter 2022 earnings released: EPS: US$1.30 (vs US$0.91 in 2Q 2021) Aug 03
Innospec Inc. to Report Q2, 2022 Results on Aug 02, 2022 Jul 08
Investor sentiment improved over the past week Jul 02
First quarter 2022 earnings released: EPS: US$1.47 (vs US$0.95 in 1Q 2021) May 05
Innospec Inc. Declares Semi-Annual Dividend for the First Half of 2022, Payable on May 26, 2022 May 05
Innospec Inc. to Report Q1, 2022 Results on May 03, 2022 Apr 07
President recently sold €601k worth of stock Mar 04
Innospec Inc. (NasdaqGS:IOSP) announces an Equity Buyback for $50 million worth of its shares. Feb 18
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Feb 16
Innospec Secures China Approval for Its Ultra-Mild, Sulfate-Free Iselux® Surfactants Jan 06
President recently sold €968k worth of stock Nov 15
Third quarter 2021 earnings released: EPS US$0.95 (vs US$0.52 in 3Q 2020) Nov 04
Second quarter 2021 earnings released: EPS US$0.91 (vs US$1.62 loss in 2Q 2020) Aug 04
President recently sold €382k worth of stock May 13
First quarter 2021 earnings released: EPS US$0.95 (vs US$1.35 in 1Q 2020) May 06
Innospec Inc. Announces Semi-Annual Dividend for the First Half of 2021, Payable on May 26, 2021 May 05
Senior Vice President of Corporate Development & Investor Relations Brian Watt has left the company May 04
Innospec Inc., Annual General Meeting, May 05, 2021 Mar 20
New 90-day high: €84.00 Feb 26
Brian Watt Informs His Decision to Retire as Senior Vice President, Corporate Development and Investor Relations of Innospec Inc., Effective April 30, 2021 Feb 26
Full year 2020 earnings released: EPS US$1.17 (vs US$4.58 in FY 2019) Feb 19
Revenue beats expectations Feb 19
Innospec Inc. to Report Q4, 2020 Results on Feb 16, 2021 Jan 19
Investor sentiment improved over the past week Jan 09
New 90-day high: €78.00 Jan 08
New 90-day high: €73.50 Dec 19
Market bids up stock over the past week Nov 26
New 90-day high: €69.00 Nov 16
Market bids up stock over the past week Nov 16
Upcoming Dividend of US$0.52 Per Share Nov 09
Third quarter 2020 earnings released: EPS US$0.52 Nov 05
Revenue misses expectations Nov 05
Innospec Inc. Appoints Elizabeth Keller Arnold as A Non-Employee Director Nov 03
Innospec Inc. to Report Q3, 2020 Results on Nov 03, 2020 Oct 08
New 90-day low: €53.00 Sep 25
New 90-day low - €60.50 Sep 09
First half earnings released Aug 06
Innospec Inc. to Report Q2, 2020 Results on Aug 04, 2020 Jul 08 Shareholder Returns OCT DE Chemicals DE Market 7D -4.6% -2.5% -2.0% 1Y -7.1% -8.9% 6.9%
See full shareholder returns
Return vs Market: OCT underperformed the German Market which returned 6.9% over the past year.
Price Volatility Is OCT's price volatile compared to industry and market? OCT volatility OCT Average Weekly Movement 3.7% Chemicals Industry Average Movement 3.9% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.3% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: OCT has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: OCT's weekly volatility (4%) has been stable over the past year.
About the Company Founded Employees CEO Website 1938 2,400 Patrick Williams innospec.com
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company’s Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels. This segment’s products are used in the operation of commercial trucking, marine and aviation engines, power station generators, heating oil, and other industrial machinery applications.
Show more Innospec Inc. Fundamentals Summary How do Innospec's earnings and revenue compare to its market cap? OCT fundamental statistics Market cap €2.62b Earnings (TTM ) €137.72m Revenue (TTM ) €1.79b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) OCT income statement (TTM ) Revenue US$1.87b Cost of Revenue US$1.31b Gross Profit US$567.40m Other Expenses US$423.60m Earnings US$143.80m
Dividends
1.4% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/23 22:59 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Innospec Inc. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Jonathan Tanwanteng CJS Securities, Inc. David Silver CL King & Associates, Inc. Sean Milligan Johnson Rice & Company, L.L.C.
Show 6 more analysts